<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle><![CDATA[EAGER: High-throughput early detection and analysis of COVID-19 plaque formation using time-lapse coherent imaging and deep learning]]></AwardTitle>
<AGENCY>NSF</AGENCY>
<AwardEffectiveDate>09/15/2020</AwardEffectiveDate>
<AwardExpirationDate>08/31/2023</AwardExpirationDate>
<AwardTotalIntnAmount>299947.00</AwardTotalIntnAmount>
<AwardAmount>299947</AwardAmount>
<AwardInstrument>
<Value>Standard Grant</Value>
</AwardInstrument>
<Organization>
<Code>07020000</Code>
<Directorate>
<Abbreviation>ENG</Abbreviation>
<LongName>Directorate For Engineering</LongName>
</Directorate>
<Division>
<Abbreviation>CBET</Abbreviation>
<LongName>Div Of Chem, Bioeng, Env, &amp; Transp Sys</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>Adam Wax</SignBlockName>
<PO_EMAI>awax@nsf.gov</PO_EMAI>
<PO_PHON>7032928809</PO_PHON>
</ProgramOfficer>
<AbstractNarration><![CDATA[Plaque assays are widely used for measuring the infectious concentration of viral samples and form a very important tool for vaccine development, especially for the evaluation of the performance of new vaccines at the exploratory and preclinical stages. This standard method is laborious and takes days to get the results, and is subject to human errors since it depends on manual plaque counting. Molecular techniques such as polymerase chain reaction (PCR or reverse transcription PCR) and western blots can be used to quantify the viral genome. However, none of these methods provide information about the infectivity of the virus and cannot measure plaque forming units. This proposal aims to create a computational sensor platform for accelerated testing of SARSCoV-2 viability and infectivity using deep learning-based plaque assays and achieve accurate and automated plaque forming unit (PFU) measurements within hours as opposed to days with standard plaque assays. &lt;br/&gt;&lt;br/&gt;The proposed computational imaging system will periodically capture coherent microscopic images of the cytopathogenic effects of viruses on cell cultures and analyze these time lapsed holographic images using deep neural networks (DNNs) for rapid detection of viral destruction of the cell monolayer. In addition to early and automated detection of plaque forming units, this unique platform will further make use of deep learning for high-throughput holographic image reconstruction of the assay volume to perform tile-scan imaging of the entire well plate within 5 min, corresponding to an imaging throughput of ~50 cm2/min. Powered by deep learning, this automated and cost-effective viral plaque monitoring platform can be transformative for a wide range of applications in microbiology and virology by significantly reducing the detection time without labeling or the need for an expert, or manual inspection.  The project will also establish a complementary educational outreach program that will involve (1) public interviews and popular science articles in news media and internet; (2) undergraduate research opportunities in the PIâ€™s laboratory involving minority students; and (3) graduate student training through organization of workshops, seminars and conferences. Furthermore, research projects, seminars and open house visits will serve undergrads and high school students (especially from minority groups) to interact with a cutting edge research environment, helping to increase their scientific curiosity and shaping their career goals in science and engineering.&lt;br/&gt;&lt;br/&gt;This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.]]></AbstractNarration>
<MinAmdLetterDate>07/20/2020</MinAmdLetterDate>
<MaxAmdLetterDate>07/20/2020</MaxAmdLetterDate>
<ARRAAmount/>
<TRAN_TYPE>Grant</TRAN_TYPE>
<CFDA_NUM>47.041</CFDA_NUM>
<NSF_PAR_USE_FLAG>1</NSF_PAR_USE_FLAG>
<FUND_AGCY_CODE>4900</FUND_AGCY_CODE>
<AWDG_AGCY_CODE>4900</AWDG_AGCY_CODE>
<AwardID>2034234</AwardID>
<Investigator>
<FirstName>Aydogan</FirstName>
<LastName>Ozcan</LastName>
<PI_MID_INIT/>
<PI_SUFX_NAME/>
<PI_FULL_NAME>Aydogan Ozcan</PI_FULL_NAME>
<EmailAddress><![CDATA[ozcan@ee.ucla.edu]]></EmailAddress>
<NSF_ID>000488625</NSF_ID>
<StartDate>07/20/2020</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Investigator>
<FirstName>Hatice</FirstName>
<LastName>Ceylan Koydemir</LastName>
<PI_MID_INIT/>
<PI_SUFX_NAME/>
<PI_FULL_NAME>Hatice Ceylan Koydemir</PI_FULL_NAME>
<EmailAddress><![CDATA[hckoydemir@tamu.edu]]></EmailAddress>
<NSF_ID>000825473</NSF_ID>
<StartDate>07/20/2020</StartDate>
<EndDate/>
<RoleCode>Co-Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>University of California-Los Angeles</Name>
<CityName>LOS ANGELES</CityName>
<ZipCode>900246541</ZipCode>
<PhoneNumber>3107940102</PhoneNumber>
<StreetAddress>10920 WILSHIRE BLVD STE 500</StreetAddress>
<StreetAddress2/>
<CountryName>United States</CountryName>
<StateName>California</StateName>
<StateCode>CA</StateCode>
<CONGRESSDISTRICT>32</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_ORG>CA32</CONGRESS_DISTRICT_ORG>
<ORG_UEI_NUM>RN64EPNH8JC6</ORG_UEI_NUM>
<ORG_LGL_BUS_NAME>UNIVERSITY OF CALIFORNIA, LOS ANGELES</ORG_LGL_BUS_NAME>
<ORG_PRNT_UEI_NUM/>
</Institution>
<Performance_Institution>
<Name><![CDATA[University of California-Los Angeles]]></Name>
<CityName>Los Angeles</CityName>
<StateCode>CA</StateCode>
<ZipCode>900951594</ZipCode>
<StreetAddress><![CDATA[420 Westwood Plz]]></StreetAddress>
<CountryCode>US</CountryCode>
<CountryName>United States</CountryName>
<StateName>California</StateName>
<CountryFlag>1</CountryFlag>
<CONGRESSDISTRICT>36</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_PERF>CA36</CONGRESS_DISTRICT_PERF>
</Performance_Institution>
<ProgramElement>
<Code>7236</Code>
<Text>BioP-Biophotonics</Text>
</ProgramElement>
<ProgramReference>
<Code>096Z</Code>
<Text>COVID-19 Research</Text>
</ProgramReference>
<ProgramReference>
<Code>7916</Code>
<Text>EAGER</Text>
</ProgramReference>
<Appropriation>
<Code>0120</Code>
<Name>NSF RESEARCH &amp; RELATED ACTIVIT</Name>
<APP_SYMB_ID>040100</APP_SYMB_ID>
</Appropriation>
<Fund>
<Code>01002021DB</Code>
<Name><![CDATA[NSF RESEARCH & RELATED ACTIVIT]]></Name>
<FUND_SYMB_ID>040100</FUND_SYMB_ID>
</Fund>
<FUND_OBLG>2020~299947</FUND_OBLG>
<POR>
<DRECONTENT><![CDATA[<div class="porColContainerWBG"> <div class="porContentCol"><p>Viral infections have challenged humanity for centuries. Even with progressive scientific advancements, the struggle against viruses continues, as exemplified by the recent COVID-19 pandemic. In the fight against these viral infections, a variety of techniques have been established for detecting and quantifying viruses, contributing significantly to the development of critical vaccines and antiviral medications. Among these techniques, the viral plaque assay stands out as the gold standard due to its unique ability to assess virus infectivity in a cost-effective way by observing the formation of viral plaques caused by viral infections over a layer of cells. Nevertheless, the traditional viral plaque assays require an incubation period of 2-14 days, followed by sample staining using chemicals and human visual inspection to count the number of viral plaques. This procedure is time-consuming and susceptible to staining artifacts and counting errors induced by human technicians. Therefore, an accurate, automated, rapid, and cost-effective viral plaque quantification technique is urgently needed. Expediting and automating viral plaque assays will significantly benefit clinical diagnosis, vaccine development, and the production of recombinant proteins or antiviral agents.</p> <p>In this project, UCLA researchers presented a rapid and stain-free quantitative viral plaque assay using lensfree holographic imaging and deep learning. This cost-effective, compact, and automated device significantly reduces the incubation time needed for traditional plaque assays while preserving their advantages over other virus quantification methods. This device captures ~0.32 Giga-pixel/hour phase information of the objects per test well, covering an area of ~30&times;30 mm<sup>2</sup>, in a label-free manner, eliminating staining entirely. Researchers demonstrated the success of this computational method using vesicular stomatitis virus (VSV), herpes simplex virus (HSV-1) and encephalomyocarditis virus (EMCV). Using a neural network, this stain-free device automatically detected the first cell lysing events due to the VSV viral replication as early as 5 hours after the incubation, and achieved &gt;90% detection rate for the VSV plaque-forming units (PFUs) with 100% specificity in &lt;20 hours, providing major time savings compared to the traditional plaque assays that take &ge;48 hours. Similarly, this stain-free device reduced the needed incubation time by ~48 hours for HSV-1 and ~20 hours for EMCV, achieving &gt;90% detection rate with 100% specificity. They also demonstrated that this data-driven plaque assay offers the capability of quantifying the infected area of the cell monolayer, performing automated counting and quantification of PFUs and virus-infected areas over a 10-fold larger dynamic range of virus concentration than standard viral plaque assays. This compact, low-cost, automated PFU quantification device can be broadly used in virology research, vaccine development, and clinical applications.</p><br> <p>  Last Modified: 12/22/2023<br> Modified by: Aydogan&nbsp;Ozcan</p></div> <div class="porSideCol" ><div class="each-gallery"> <div class="galContent" id="gallery0"> <div class="photoCount" id="photoCount0">          Image         </div> <div class="galControls onePhoto" id="controls0"></div> <div class="galSlideshow" id="slideshow0"></div> <div class="galEmbox" id="embox"> <div class="image-title"></div> </div> </div> <div class="galNavigation onePhoto" id="navigation0"> <ul class="thumbs" id="thumbs0"> <li> <a href="/por/images/Reports/POR/2023/2034234/2034234_10687031_1703231120709_TOC_Image__2_--rgov-214x142.jpg" original="/por/images/Reports/POR/2023/2034234/2034234_10687031_1703231120709_TOC_Image__2_--rgov-800width.jpg" title="Viral plaque detection system enabled by holography and deep learning."><img src="/por/images/Reports/POR/2023/2034234/2034234_10687031_1703231120709_TOC_Image__2_--rgov-66x44.jpg" alt="Viral plaque detection system enabled by holography and deep learning."></a> <div class="imageCaptionContainer"> <div class="imageCaption">a, Photograph of the holographic imaging device, together with a processing laptop for AI-powered smart viral plaque detection system, b-c, Comparison of the AI-powered smart viral plaque identification results against the traditional  chemical staining-based plaque assay.</div> <div class="imageCredit">Ozcan Lab @UCLA</div> <div class="imagePermisssions">Copyrighted</div> <div class="imageSubmitted">Aydogan&nbsp;Ozcan <div class="imageTitle">Viral plaque detection system enabled by holography and deep learning.</div> </div> </li></ul> </div> </div></div> </div>]]></DRECONTENT>
<POR_COPY_TXT><![CDATA[  Viral infections have challenged humanity for centuries. Even with progressive scientific advancements, the struggle against viruses continues, as exemplified by the recent COVID-19 pandemic. In the fight against these viral infections, a variety of techniques have been established for detecting and quantifying viruses, contributing significantly to the development of critical vaccines and antiviral medications. Among these techniques, the viral plaque assay stands out as the gold standard due to its unique ability to assess virus infectivity in a cost-effective way by observing the formation of viral plaques caused by viral infections over a layer of cells. Nevertheless, the traditional viral plaque assays require an incubation period of 2-14 days, followed by sample staining using chemicals and human visual inspection to count the number of viral plaques. This procedure is time-consuming and susceptible to staining artifacts and counting errors induced by human technicians. Therefore, an accurate, automated, rapid, and cost-effective viral plaque quantification technique is urgently needed. Expediting and automating viral plaque assays will significantly benefit clinical diagnosis, vaccine development, and the production of recombinant proteins or antiviral agents.   In this project, UCLA researchers presented a rapid and stain-free quantitative viral plaque assay using lensfree holographic imaging and deep learning. This cost-effective, compact, and automated device significantly reduces the incubation time needed for traditional plaque assays while preserving their advantages over other virus quantification methods. This device captures ~0.32 Giga-pixel/hour phase information of the objects per test well, covering an area of ~3030 mm2, in a label-free manner, eliminating staining entirely. Researchers demonstrated the success of this computational method using vesicular stomatitis virus (VSV), herpes simplex virus (HSV-1) and encephalomyocarditis virus (EMCV). Using a neural network, this stain-free device automatically detected the first cell lysing events due to the VSV viral replication as early as 5 hours after the incubation, and achieved 90% detection rate for the VSV plaque-forming units (PFUs) with 100% specificity in      Last Modified: 12/22/2023       Submitted by: AydoganOzcan]]></POR_COPY_TXT>
</POR>
</Award>
</rootTag>
